Paysign, Inc. to Present at The Benchmark Company’s Upcoming Discovery One-on-One Investor Conference
November 17 2022 - 04:30PM
Business Wire
Paysign, Inc. (NASDAQ: PAYS), a leading provider of
prepaid card programs, comprehensive patient affordability
offerings, digital banking services and integrated payment
processing, today announced it will be presenting at The Benchmark
Company’s 11th Annual Discovery One-on-One Investor Conference to
be held Thursday, December 1, 2022, at the New York Athletic Club
in New York City.
Paysign is scheduled to participate in one-on-one meetings with
institutional analysts and investors throughout the day.
The conference offers emerging growth and dynamic publicly
traded companies access to institutional and individual investors
in a unique one-on-one format.
To schedule a one-on-one meeting with Paysign, investors may
submit a request online via the link provided upon registration. To
register for the conference, please visit The Benchmark Company’s
event website.
About The Benchmark Company
The Benchmark Company is an institutionally focused, research
driven, sales trading and investment banking firm. We were founded
in 1988 and are headquartered in New York City. Our focus is on
fostering the long-term success of our corporate clients through
raising capital, providing strategic advisory services, generating
insightful research and developing institutional sponsorship by
leveraging the firm’s sales, trading and equity research
capabilities. benchmarkcompany.com.
Forward-Looking Statements
Certain statements in this press release may be considered
forward-looking under federal securities laws, and the company
intends that such forward-looking statements be subject to the safe
harbor created thereby. All statements, besides statements of fact
included in this release are forward-looking. Such forward-looking
statements include, among others, that our unrestricted cash,
anticipated revenues and operating profits will be sufficient to
sustain operations for the next 12 months; that the expected total
revenue, gross profit margins, operating expenses, depreciation and
amortization, stock-based compensation, Adjusted EBITDA, plasma
revenues and pharma revenues for 2022 meet our expectations; that
the company will continue to post year-over-year operating
improvements; that the company’s growth prospects in plasma, pharma
and other prepaid business materialize; and that the company will
continue to be affected by COVID-19. We caution that these
statements are qualified by important risks, uncertainties and
other factors that could cause actual results to differ materially
from those reflected by such forward-looking statements. Such
factors include, among others, the inability to continue our
current growth rate in future periods; that a downturn in the
economy, including as a result of COVID-19 and variants, as well as
further government stimulus measures, could reduce our customer
base and demand for our products and services, which could have an
adverse effect on our business, financial condition, profitability
and cash flows; operating in a highly regulated environment;
failure by us or business partners to comply with applicable laws
and regulations; changes in the laws, regulations, credit card
association rules or other industry standards affecting our
business; that a data security breach could expose us to liability
and protracted and costly litigation; and other risk factors set
forth in our Form 10-K for the year ended December 31, 2021. Except
to the extent required by federal securities laws, the company
undertakes no obligation to publicly update or revise any
statements in this release, whether as a result of new information,
future events or otherwise.
About Paysign
Paysign, Inc. is a leading provider of prepaid card programs,
comprehensive patient affordability offerings, digital banking
services and integrated payment processing designed for businesses,
consumers and government institutions. Incorporated in 1995 and
headquartered in southern Nevada, the company creates customized,
innovative payment solutions for clients across all industries,
including pharmaceutical, healthcare, hospitality and retail. Built
on the foundation of a reliable payments platform, Paysign’s
end-to-end technologies securely enable digital payout solutions
and facilitate the distribution of funds for donor compensation,
copay assistance, customer incentives, employee rewards, travel
expenses, per diem, reimbursements, rebates and countless other
exchanges of value. Paysign’s solutions lower costs, streamline
operations and improve customer, employee and partner loyalty. To
learn more, visit paysign.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20221117006078/en/
Paysign Investor Relations 888.522.4810 ir@paysign.com
paysign.com/investors
Paysign Media Relations Alicia Ches, Director of
Marketing 702.749.7257 pr@paysign.com
Paysign (NASDAQ:PAYS)
Historical Stock Chart
From Jan 2023 to Feb 2023
Paysign (NASDAQ:PAYS)
Historical Stock Chart
From Feb 2022 to Feb 2023